AI Article Synopsis
- Ergotamine tartrate was administered intravenously to 17 migraine patients, leading to a temporary increase in arm blood pressure and a significant and sustained decrease in peripheral blood pressure over 22 hours.
- An additional group of 10 migraine patients received ergotamine tartrate as suppositories, showing a decrease in peripheral blood pressure within 24 hours that faded by 48 hours.
- The study challenges the typical perception of ergotamine's effects, indicating that its vasoconstrictory impact on arteries lasts longer than previously thought and should be monitored for several days after administration.
Article Abstract
Ergotamine tartrate (0.5 mg/70 kg) was given intravenously to 17 migraine patients. Arm, finger, ankle and big toe systolic blood pressures were measured with strain gauge technique for up to 4 hours and again after 22 hours. Systolic arm blood pressure increased transiently (duration less than 3 hours). Peripheral systolic blood pressures decreased in all patients (for toes a few to 55 mmHg) and at 22 hours well sustained decreases were still found. Further 10 migraine patients received 2-4 mg ergotamine tartrate as suppositories and peripheral systolic blood pressures were measured for 3 days. A decrease in peripheral systolic blood pressure was found after 24 hours but had disappeared after 48 hours. Contrary to common belief the present study investigating the effect of ergotamine directly on arteries has shown a long duration of its vasoconstrictory effect. Thus the effect of a single dose of ergotamine on the arteries should be followed for days.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1600-0773.1980.tb01855.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!